Filing Flows › Bausch Health Companies (BHC) › Capital expenditures
Bausch Health Companies (BHC) capital expenditures by quarter
Bausch Health Companies' capital expenditures were $66.0M in Q3 2026 (third quarter 2026), -14% from Q2 2026. Over the last 7 quarters it ranged from $66.0M (Q3 2026) to $115M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $66.0M | -14% | -27% |
| Q2 2026 | $77.0M | -29% | -22% |
| Q1 2026 | $109M | +18% | -5% |
| Q4 2025 | $92.0M | +1% | — |
| Q3 2025 | $91.0M | -8% | — |
| Q2 2025 | $99.0M | -14% | — |
| Q1 2025 | $115M | — | — |
Q3 2026 at a glance
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bausch Health Companies' capital expenditures?
Bausch Health Companies' capital expenditures were $66.0M in Q3 2026 (third quarter 2026), -14% from Q2 2026.
How has Bausch Health Companies' capital expenditures changed?
Over the last 7 quarters it ranged from $66.0M (Q3 2026) to $115M (Q1 2025).
Q3 2026 results → · How Bausch Health Companies makes money →